Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan

被引:0
|
作者
Nguyen, Teresa [1 ]
Bareham, Julia [2 ]
Halpape, Katelyn [3 ]
机构
[1] Loblaw Pharm Saskatoon, Saskatoon, SK, Canada
[2] Univ Saskatchewan, RxFiles Acad Detailing Program, Saskatoon, SK, Canada
[3] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada
关键词
COLLABORATIVE CARE; BUPRENORPHINE; EXPERIENCE; ABSTINENCE; ADDICTION; METHADONE;
D O I
10.46747/cfp.7004e52
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective To explore barriers and facilitators for family physicians in Saskatchewan prescribing opioid agonist therapy (OAT). Design Self-administered postal survey. Setting Family medicine practices in Saskatchewan. Participants A total of 218 Saskatchewan family physicians who were not authorized to prescribe OAT as of June 2022. Main outcome measures Descriptive and inferential statistics of physicians' self-reported barriers to and facilitators of prescribing OAT for opioid use disorder (OUD). Results Most respondents (84.8%) had some comfort with diagnosing OUD. However, more than half (58.3%) did not feel confident or knowledgeable about prescribing OAT. Barriers to OAT prescribing included lack of time, incomplete training requirements, lack of interest, insufficient funding or support, feeling overwhelmed, and perceiving that OAT does not work and thus is not necessary. Physicians working in core neighbourhoods and those receiving fee-for-service compensation reported the least available time to prescribe OAT. Conversely, physicians working in interdisciplinary team settings had increased time for OAT prescribing compared with physicians in other settings. Having a close personal relationship with someone with OUD was correlated with increased comfort in diagnosing OUD as well as with knowledge about and confidence in prescribing OAT. Themes identified as facilitators to increasing OAT prescribing included the addition of resources and supports, increased training, more awareness about OUD and OAT, enhanced compensation, and altered prescribing regulations. Conclusion Despite the presence of several real and perceived barriers limiting OAT prescribing by Saskatchewan family physicians, there are family physicians interested in providing this therapy. Increased clinical resources and support, including increased interdisciplinary practice, are actionable steps that should be considered by policy decision makers to address this issue. Additionally, increased OUD and OAT education, which includes the perspectives of those with lived experience of OUD, would help address physician confidence, knowledge, and awareness in this area.
引用
收藏
页码:e52 / e60
页数:9
相关论文
共 50 条
  • [1] Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review
    Nixon, Lara L.
    Marlinga, Jazmin C.
    Hayden, K. Alix
    Mrklas, Kelly J.
    SYSTEMATIC REVIEWS, 2019, 8 (1)
  • [2] A Cross-sectional Study of Opioid Agonist Therapy Barriers and Facilitators
    Duff, Elsie
    Fehr, Cindy
    Shams, Shahid
    Wintoniw, Steven
    Devenney, Ashley
    Ashfield, Diana
    O'Rourke, Tammy
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2024, 20 (04):
  • [3] Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review
    Pijl, Em M.
    Alraja, Abeer
    Duff, Elsie
    Cooke, Carol
    Dash, Stephen
    Nayak, Nichole
    Lamoureux, Jesse
    Poulin, Ginette
    Knight, Erin
    Fry, Ben
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2022, 17 (01)
  • [4] Barriers and facilitators to office-based opioid agonist therapy prescribing and effective interventions to increase provider prescribing: protocol for a systematic review
    Lara L. Nixon
    Jazmin C. Marlinga
    K. Alix Hayden
    Kelly J. Mrklas
    Systematic Reviews, 8
  • [5] Barriers to accessing opioid agonist therapy in pregnancy
    Bedrick, Bronwyn S.
    O'Donnell, Carly
    Marx, Christine M.
    Friedman, Hayley
    Carter, Ebony B.
    Stout, Molly J.
    Kelly, Jeannie C.
    AMERICAN JOURNAL OF OBSTETRICS & GYNECOLOGY MFM, 2020, 2 (04)
  • [6] Facilitators and Barriers to Nurse Practitioners Prescribing Methadone for Opioid Use Disorder in Nova Scotia: A Qualitative Study
    Bates, Aaron E.
    Martin-Misener, Ruth
    CANADIAN JOURNAL OF NURSING RESEARCH, 2022, 54 (01) : 15 - 26
  • [7] Barriers and facilitators to prescribing buprenorphine for treating opioid use disorder among emergency department and other practice setting physicians
    Swartz, James A.
    Franceschini, Dana
    Marino, Nora M.
    Call, Adrienne H.
    Rosenberger, Lisa
    Whitehouse, Sarah
    AIMS PUBLIC HEALTH, 2025, 12 (01): : 56 - 76
  • [8] Barriers and facilitators encountered by family physicians prescribing opioids for chronic non-cancer pain: a qualitative study
    Goodwin, Joshua
    Kirkland, Susan
    HEALTH PROMOTION AND CHRONIC DISEASE PREVENTION IN CANADA-RESEARCH POLICY AND PRACTICE, 2021, 41 (06): : 182 - 189
  • [9] Barriers and facilitators to medications for Opioid Use prescribing in primary care in the United States: a scoping review
    Ukaoma, Stella C.
    Kedia, Satish K.
    Regmi, Sanjaya
    Entwistle, Coree
    Lee, Guijin
    Dillon, Patrick J.
    DRUGS-EDUCATION PREVENTION AND POLICY, 2025,
  • [10] Physicians' experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorder
    McCollum, Greer
    Eaton, Ellen
    Creger, Thomas
    Lee, Aaron
    Gagnon, Kelly
    Li, Li
    DRUG AND ALCOHOL DEPENDENCE, 2023, 244